title: Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists.
authors.forename: S G
authors.initials: SG
authors.lastname: Parameswaran
authors.forename: C
authors.initials: C
authors.lastname: Chang
authors.forename: A K
authors.initials: AK
authors.lastname: Swenson
authors.forename: M
authors.initials: M
authors.lastname: Shumway
authors.forename: M
authors.initials: M
authors.lastname: Olfson
authors.forename: C V
authors.initials: CV
authors.lastname: Mangurian
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D005260:Female; D006306:Health Surveys; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000592:standards*; D008659:Metabolic Diseases / Q000139:chemically induced / Q000175:diagnosis; D008875:Middle Aged; D011570:Psychiatry / Q000379:methods / Q000592:standards; D012307:Risk Factors; D000078329:Workforce
chemical_list: D014150:Antipsychotic Agents